May 3, 2007 -- Venture capital raised by biotech firms worldwide rose by 42 percent to $27.9 billion for 2006, according to an annual report on the industry by Ernst & Young.
Last year, U.S.-based biotech firms raised a record-high $5.4 billion, while the total value of domestic mergers and acquisitions reached $23 billion, the report said.
According to industry watchers cited in the report, the sector's steady growth is expected to continue this year.
- next -
No. 1 on the Inc. 5000: Meet the Fastest-Growing Company in America
5 Common Startup Mistakes That Will Sink You Later
A No-Nonsense Guide to Starting Up
Every Startup Should Focus on These 4 Things
5 Tips to Keep Your Home-Based Business Legal